Session Details
[LS-15]Luncheon Seminar 15 Considering the Meaningful Benefit of Anti-amyloid-β Antibody Therapy
Thu. May 22, 2025 12:00 PM - 1:00 PM JST
Thu. May 22, 2025 3:00 AM - 4:00 AM UTC
Thu. May 22, 2025 3:00 AM - 4:00 AM UTC
第03会場(大阪国際会議場10F 会議室1003)
Chair: Kenjiro Ono（Department of Neurology and Neurobiology and Aging, Kanazawa University Graduate School of Medical Sciences, Japan）
Sponsored by: Eli Lilly Japan K.K.
[LS-15-1]Considering the Meaningful Benefit of Anti-amyloid-β Antibody Therapy
Masafumi Ihara (Department of Neurology, National Cerebral and Cardiovascular Center, Japan)